Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Health / Medical

Annovis Bio
Research

Annovis Bio Launches Phase 3 Trial for Alzheimer’s Drug Buntanetap

February 6, 2025February 5, 2025 - by Timothy Alexander

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has initiated its pivotal Phase 3 clinical trial evaluating buntanetap as a treatment for early Alzheimer’s disease (AD), marking an important step forward …

Annovis Bio Launches Phase 3 Trial for Alzheimer’s Drug Buntanetap Read More

Food and Drug Administration
Health / Medical / National

FDA Approves First-in-Class Non-Opioid Pain Drug Journavx

February 3, 2025February 3, 2025 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking non-opioid analgesic designed to treat moderate to severe acute pain …

FDA Approves First-in-Class Non-Opioid Pain Drug Journavx Read More
Maternal Healthcare Roundtable
Health / Medical / Pennsylvania

How Pennsylvania’s Bold Action on Maternal Health and Addiction Could Change Lives Forever

February 2, 2025February 2, 2025 - by Maryann Pugh

WEST CHESTER, PA — Pennsylvania state leaders convened on Friday for a groundbreaking roundtable to address the critical intersection of maternal health and substance use disorders (SUD). The discussion, hosted by …

How Pennsylvania’s Bold Action on Maternal Health and Addiction Could Change Lives Forever Read More

West Chester Cardiac Rehab
Cardiology / Products and Services

West Chester Rehabilitation & Healthcare Center Launches Cardiac Rehab Program

January 29, 2025January 29, 2025 - by Timothy Alexander

WEST CHESTER, PA — West Chester Rehabilitation & Healthcare Center has introduced a Cardiac Rehabilitation program designed to enhance recovery and quality of life for heart patients. This new initiative focuses …

West Chester Rehabilitation & Healthcare Center Launches Cardiac Rehab Program Read More
Ocugen
Research

Ocugen Receives FDA Greenlight for Phase 1 Trial of Mucosal COVID-19 Vaccine

January 29, 2025January 28, 2025 - by Timothy Alexander

MALVERN, PA — Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for OCU500, a novel …

Ocugen Receives FDA Greenlight for Phase 1 Trial of Mucosal COVID-19 Vaccine Read More

DOH Maternal Health
Health / Medical / Pennsylvania

Shapiro Administration Bolsters Maternal Health with New Initiatives and Funding

January 28, 2025January 28, 2025 - by Maryann Pugh

HERSHEY, PA — The Shapiro Administration has announced a comprehensive strategy to improve maternal health outcomes in Pennsylvania. This effort includes funding for four regional maternal health coalitions and a commitment …

Shapiro Administration Bolsters Maternal Health with New Initiatives and Funding Read More
HMP Global
Cancer

HMP Global Unveils Comprehensive Oncology Series, Great Debates in Solid Tumors

January 28, 2025January 27, 2025 - by Timothy Alexander

MALVERN, PA — HMP Global has announced the debut of its 2025 Great Debates in Solid Tumors series, combining the best of its three Great Debates programs into a dynamic educational …

HMP Global Unveils Comprehensive Oncology Series, Great Debates in Solid Tumors Read More

Nurse and Cancer Survivor Creates Care Bags for Patients at Chester County Hospital
Cancer

Survivor’s Touch: Nurse Transforms Cancer Care with Heartfelt Comfort Bags

January 23, 2025January 23, 2025 - by Timothy Alexander

WEST CHESTER, PA — At Chester County Hospital, Christina Ferrarini, BSN, RN, CAPA, is going above and beyond for cancer patients, inspired by her own battle with the disease. Ferrarini, a …

Survivor’s Touch: Nurse Transforms Cancer Care with Heartfelt Comfort Bags Read More
Verrica Pharmaceuticals Inc
Health / Medical

Verrica Showcases Promising VP-315 Data at Dermatology Conference

January 23, 2025January 22, 2025 - by Timothy Alexander

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) unveiled encouraging clinical data for its investigational therapy, VP-315, at the 2025 Winter Clinical Dermatology Conference in Miami, Florida. The Phase 2 …

Verrica Showcases Promising VP-315 Data at Dermatology Conference Read More
Vaccination
Infectious Diseases / National

HHS Provides $590 Million to Moderna for Pandemic Influenza Vaccine Development

January 22, 2025January 20, 2025 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) has announced $590 million in funding to Moderna to expedite the development of mRNA-based vaccines aimed at combating …

HHS Provides $590 Million to Moderna for Pandemic Influenza Vaccine Development Read More

Posts pagination

Previous 1 … 43 44 45 … 51 Next

Trending News

  • Pa. House Advances AI Disclosure Bill for Consumer Sales

  • New Hope and Lambertville Plan Massive America 250 Festival Across Two States

  • Chester County Appoints New Voter Services Director Ahead of Election Cycle

  • Pocopson Township: The Quiet Community at the Center of History

  • Dairy Queen Cited for Labeling, Plumbing Issues in Health Inspection

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Todd Hill

Swim School Manager Charged in Juvenile Sexual Assault Case

7 hours ago12 hours ago

John Wallace-Bey

Suspect Charged After Deadly Shooting at Wilmington Hospital

8 hours ago12 hours ago

Kohl's suspects

Police Need Help Identifying Suspects in Exton Retail Theft

9 hours ago12 hours ago

Copyright © 2026 MyChesCo.